What the Evidence Does NOT Show Because the marketing around these compounds is expansive, it is worth stating explicitly what the published record does not establish: It does not show that cagrilintide is superior, equal, or inferior to tirzepatide no head-to-head trial exists, so any ranking is cross-trial inference
10.3390/nu15194297 17 BaiX.TanT.-Y.LiY.-X.LiY.ChenY.-F.MaR.et al (2020)
The narrow pocket of mTYR and the long side chain of CME limit the available conformations for CME during the docking process
A total of 30 randomized samples (WT n = 10, ADH5 n = 10, WT + 150 mol L 1 FA n = 5, ADH5 + FA n = 5) were analysed along 3 consecutive days
Serving Size: 1 Capsule Servings per container: 60 BPC-157 (Naturally occurring acetylate & amidated form for BPC-157) 500 mcg ** **Daily Value not established Other Ingredients: Microcrystalline Cellulose, Delayed Released Veggie Capsule